Calculate Your Salary Ranking
Home > Cytrx Salary

Cytrx Salary
  • 61
  • 59
  • 68

Cytrx average salary is $98,032, median salary is $105,000 with a salary range from $78,000 to $108,160.
Cytrx salaries are collected from government agencies and companies. Each salary is associated with a real job position. Cytrx salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
78,000
Average
98,032
Median
105,000
High
108,160
Total 5 Cytrx Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Controller 105,000-105,000 Los Angeles, CA, 90001 2014 Cytrx Controller Salaries (2)
Cytrx Los Angeles, CA Salaries
Accountants & Auditors 94,000-94,000 Los Angeles, CA, 90049 2013 Cytrx Accountants & Auditors Salaries (1)
Cytrx Los Angeles, CA Salaries
Controller 105,000-105,000 Los Angeles, CA, 90001 2012 Cytrx Controller Salaries (2)
Cytrx Los Angeles, CA Salaries
Assistant Project Manager 108,160-108,160 Los Angeles, CA, 90001 2012 Cytrx Assistant Project Manager Salaries (1)
Cytrx Los Angeles, CA Salaries
Research Scientist I 78,000-78,000 San Diego, CA, 92101 2010 Cytrx Research Scientist I Salaries (1)
Cytrx San Diego, CA Salaries
1
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Cytrx Salaries (May 27, 2016)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Cytrx salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Cytrx Information
  • CytRx Corporation
  • Industry: BioTech/Drugs
  • City: Los Angeles, CA
  • CytRx Corporation is a biopharmaceutical company engaged in the development and commercialization of large market opportunity products in a variety of therapeutic categories. The company recently has formed a broad- based strategic alliance with the University of Massachusetts Medical School to develop novel compounds for obesity, diabetes and oncology based on a promising new technology known as RNA interference (RNAi). CytRx is seeking strategic partners to complete the development of FLOCOR, a product for the treatment of sickle cell disease and which may have applications in cancer and disorders such as stroke and heart attack. The company has licensed its